MedPath

The investigation for the usefulness of carnitine medication in patients with decompensated liver cirrhosis

Not Applicable
Conditions
decompensated liver cirrhosis
Registration Number
JPRN-UMIN000040441
Lead Sponsor
Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
0
Inclusion Criteria

Not provided

Exclusion Criteria

1)The patient who has already taken carnitine 2)The pregnant woman 3)The breast-feeding women 4)The patient who received other study medicine or the clinical experimental medicine within three months before dosage start of the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the improvement rate of Child-Pugh score after 12weeks from medication start
Secondary Outcome Measures
NameTimeMethod
the change of grasping power, muscle mass, serum ammonia, neuropsychological test
© Copyright 2025. All Rights Reserved by MedPath